Singapore markets open in 5 hours 22 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,060.55 +42.16 (+0.84%) Dow
38,187.55 +284.26 (+0.75%) Nasdaq
15,826.95 +221.46 (+1.42%) Bitcoin USD
59,065.11 +1,874.29 (+3.28%) CMC Crypto 200
1,274.74 +4.00 (+0.31%)
ABT Jun 2024 55.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:18PM EDT. Market open.
| Previous close | 52.25 |
| Open | N/A |
| Bid | 48.35 |
| Ask | 49.70 |
| Strike | 55.00 |
| Expiry date | 2024-06-21 |
| Day's range | 52.25 - 52.25 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.